Bharat Book Bureau Provides the Trending Market Research Report on “Opioid Overdose - Pipeline Insight, 2019”under Life Sciences Category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports.

Opioid Overdose - Pipeline Insight, 2019 report outlays comprehensive insights of present scenario and growth prospects across the indication. A detailed picture of the Opioid Overdose pipeline landscape is provided which includes the disease overview and Opioid Overdose treatment guidelines. The assessment part of the report embraces, in depth Opioid Overdose commercial assessment and clinical assessment of the pipeline products under development. In the report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Opioid Overdose collaborations, licensing, mergers and acquisition, funding, designations and other product related details

Request a free sample copy Opioid Overdose - Pipeline Insight @
https://www.bharatbook.com/marketreports/sample/reports/1852562

Opioid Overdose Understanding
According to World Health Organization, Opioids are substances derived from the opium poppy, or synthetic analogues with similar effects. Examples are morphine, heroin, tramadol, oxycodone and methadone. An overdose occurs when larger quantities than physically tolerated are taken, resulting in central nervous system and respiratory depression, miosis, and apnea, which can be fatal if not treated rapidly. An opioid overdose can be identified by a combination of three signs and symptoms referred to as the “opioid overdose triad”. The symptoms of the triad are: pinpoint pupil, unconsciousness, and respiratory depression.

Opioids have the potential to cause substance dependence that is characterized by a strong desire to take opioids, impaired control over opioid use, persistent opioid use despite harmful consequences, a higher priority given to opioid use than to other activities and obligations, increased tolerance, and a physical withdrawal reaction when opioids are discontinued. The signs and symptoms of an opioid overdose include, the person's face is extremely pale and/or feels clammy to the touch, body goes limp, fingernails or lips have a purple or blue color, vomiting, are unable to speak, and breathing or heartbeat slows or stops.

Opioid Overdose Pipeline Development Activities
The report provides insights into different therapeutic candidates in discovery and preclinical, phase 1, phase 2, and phase 3 stage. Drugs under development as a monotherapy or combination therapy are also included. It also analyses key players involved in Opioid Overdose targeted therapeutics development with respective active and inactive (dormant or discontinued) projects with the appropriate reasons if available. Opioid Overdose pipeline report covers 12+ companies. Some of the key players include Orexo (OX124), Adapt Pharma (AP 003) etc.

The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university web sites and industry-specific third party sources, etc.

Scope of the report
• The Opioid Overdose report provides an overview of therapeutic pipeline activity for Opioid Overdose across the complete product development cycle including all clinical and non-clinical stages
• It comprises of detailed profiles of Opioid Overdose therapeutic products with key coverage of developmental activities including technology, collaborations, licensing, mergers and acquisition, funding, designations and other product related details
• Detailed Opioid Overdose Research and Development progress and trial details, results wherever available, are also included in the pipeline study
• Therapeutic assessment of the active pipeline products by development stage, product type, route of administration, molecule type, and MOA type
• Coverage of dormant and discontinued pipeline projects along with the reasons if available across Opioid Overdose

Reasons to Buy
• Establish a comprehensive understanding of the current pipeline scenario across Opioid Overdose to formulate effective R&D strategies
• Assess challenges and opportunities that influence Opioid Overdose R&D
• Develop strategic initiatives by understanding the focus areas of leading companies.
• Gather impartial perspective of strategies of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
• Get in detail information of each product with updated information on each project along with key milestones
• Devise Opioid Overdose in licensing and out licensing strategies by identifying prospective partners with progressing projects for Opioid Overdose to enhance and expand business potential and scope
• Our extensive domain knowledge on therapy areas support the clients in decision-making process regarding their therapeutic portfolio by identifying the reason behind the inactive or discontinued drugs

Browse our full report with Table of Content :
https://www.bharatbook.com/marketreports/opioid-overdose-pipeline-insight-2019/1852562

About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 4,80,000 reports and insights that includes latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.

Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: [email protected]
Website: www.bharatbook.com